In 2023, Resmed completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Resmed has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Resmed amounted to 28,392 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Resmed increased by 13.3%, suggesting that the company faced challenges in reducing its emissions from its core operations.
In 2023, the total Scope 1 emissions of Resmed were 4,453 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Since 2021, Resmed's Scope 1 emissions have increased by 84.16%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Resmed's Scope 1 emissions increased by 18.97%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
In 2023, Resmed reported Scope 2 greenhouse gas (GHG) emissions of 23,939 tCOâ‚‚e without specifying the calculation method.
Since 2021, Resmed's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Resmed 's emissions have plateaued with no significant change in its energy consumption footprint.
Compared to the previous year (2022), Resmed's Scope 2 emissions (Unspecified Calculation Method) rose by 12.3% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
In 2023, Resmed reported its Scope 2 emissions using an unspecified methodology.